Maximus (NYSE:MMS – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.
Maximus Price Performance
MMS stock opened at $72.92 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.49 and a current ratio of 1.49. The firm has a market capitalization of $4.40 billion, a price-to-earnings ratio of 14.58 and a beta of 0.73. The firm has a 50 day moving average price of $78.96 and a 200-day moving average price of $85.66. Maximus has a 52-week low of $69.72 and a 52-week high of $93.97.
Insider Activity
In other news, insider Michelle F. Link sold 1,363 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the sale, the insider now owns 6,567 shares in the company, valued at $607,841.52. This represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Raymond B. Ruddy purchased 3,490 shares of Maximus stock in a transaction that occurred on Thursday, December 12th. The shares were purchased at an average cost of $71.46 per share, with a total value of $249,395.40. Following the transaction, the director now directly owns 112,520 shares of the company’s stock, valued at $8,040,679.20. This represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 7,063 shares of company stock worth $502,017 over the last three months. 1.40% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What is a buyback in stocks? A comprehensive guide for investors
- Top 3 ETFs to Hedge Against Inflation in 2025
- Short Selling: How to Short a Stock
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.